NeoGenomics said last week it finalized an agreement to acquire GE Healthcare‘s (NYSE:GE) cancer diagnostic subsidiary Clarient for up to $275 million. GE Healthcare originally purchased Clarient for nearly double that price at approximately $587 million in 2011. NeoGenomics said the acquisition would allow it to broaden its cancer diagnostic testing offerings to both hospitals and physicians […]
GE Healthcare
GE Healthcare’s Q3 sales, profits slide
Sales and profits both slid for GE Healthcare (NYSE:GE) during the 3rd quarter, as parent company General Electric saw its overall numbers slide amid its exit from the financial services business, but the industrial conglomerate still managed to top earnings expectations. GE Healthcare posted profits of $652 million on sales of $4.26 billion for the 3 months […]
GE Ventures, Startup Health reup digital health incubator
GE Ventures (NYSE:GE) and health innovation company StartUp Health said they plan to expand their partnership to invest and support startups in the healthcare innovation sector. The expansion will allow the partners to accept 10 new qualified companies into their “StartUp Health Academy” program. The 2 companies originally launched their startup focused partnership program in 2013 with […]
GE Healthcare starts $300m emerging markets push
GE Healthcare (NYSE:GE) today said it is launching a new $300 million “Sustainable Healthcare Solutions” business that will be focused on low-cost, high-value technology for emerging markets. The newly created division is part of a multi-phase effort by the company to expand its healthcare portfolio and will combine GE Healthcare’s operations in Africa, India, south Asia and […]
SEC charges trio with insider trading in GE Healthcare’s Clarient buy
The Securities and Exchange Commission said today it charged a trio of individuals with insider training related to GE Healthcare‘s (NYSE:GE) purchase of cancer diagnostic company Clarient. The individuals include a father, son and personal friend accused of abusing confidential information the father learned from a close friend working at 1 of the companies, according to […]
FDA clears GE Healthcare’s low-dose lung cancer CT
GE Healthcare (NYSE:GE) said today the FDA granted it clearance for low-dose lung cancer screenings using its compatible computed tomography devices. The Centers for Medicare and Medicaid services recommends the low-dose CT lung cancer screening and approved insurance reimbursement for high-risk patient beneficiaries who undergo the procedure, GE Healthcare said. “Bringing low dose CT screening to […]
Capital One buys GE Healthcare’s finance unit for $9B
Capital One yesterday said it signed an agreement to purchase GE Healthcare‘s (NYSE:GE) Financial Services business and healthcare-related loans, including funds used to finance medical device development. The healthcare financing arm supplies funds to companies in various healthcare sectors, including healthcare services, seniors housing, hospitals, medical offices, pharmaceuticals in addition to medical devices, the company […]
GE Healthcare’s Q2 sales, profits decline
Both the top and bottom lines declined about -3% for GE Healthcare during the 2nd quarter, General Electric reported last week. GE Healthcare posted profits of $705 million on $4.34 billion in sales for the 3 months ended June 30, down -3.3% and -3.4%, respectively. The industrial conglomerate still managed to beat expectations with its […]
Abbott, GE Healthcare ink afib deal
GE Healthcare to exit hospital EMR biz
GE Healthcare (NYSE:GE) reportedly confirmed that it’s getting out of the hospital electronic medical records business, aiming for a "graceful transition" for customers using its Centricity Enterprise EMR system.